SeaWorld Entertainment, Inc. (NYSE:SEAS) shares moved down -0.15% in last trading session and ended the day at $19.86. SEAS Gross Margin is 58.40% and its has a return on assets of 2.00%. SeaWorld Entertainment, Inc. (NYSE:SEAS) quarterly performance is 9.24%.
SeaWorld Entertainment, Inc. (NYSE:SEAS) announced that it will release its first quarter 2016 financial results before the market opens on Thursday, May 5, 2016. In conjunction with the release, the company has scheduled a conference call, which will be broadcast live over the internet, on Thursday, May 5, 2016 at 9 a.m. Eastern Time.
Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) shares fell -5.50% in last trading session and ended the day at $2.92. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) quarterly performance is 76.97%.
On 18 April, Conatus Pharmaceuticals (NASDAQ:CNAT) announced its principal investigator in a Phase 2 liver cirrhosis clinical trial, Catherine Frenette, made a late-breaker oral presentation at The International Liver Congress 2016, the annual meeting of the European Association for the Study of the Liver held in Spain last week.
On 25 April, Penns Woods Bancorp Inc. (NASDAQ:PWOD) shares increased 0.61% and was closed at $41.49. PWOD EPS growth in last 5 year was 0.40%. Penns Woods Bancorp Inc. (NASDAQ:PWOD) year to date (YTD) performance is -2.28%.
Penns Woods Bancorp Inc. (NASDAQ:PWOD) has announced that the Company’s Board of Directors has authorized the extension of its repurchase plan. The repurchase plan is for an additional year ending April 30, 2017 and allows for the repurchase of up to 482,000 shares of which approximately 19% has been repurchased to date.
DragonWave Inc. (NASDAQ:DRWI) shares moved down -6.69% in last trading session and ended the day at $5.72. DRWI Gross Margin is 19.50% and its has a return on assets of -36.10%. DragonWave Inc. (NASDAQ:DRWI) quarterly performance is -91.68%.
On 19 April, DragonWave Inc. (NASDAQ:DRWI) announced it has received a first direct order from an existing customer, Eding Telecom, who previously purchased FlexiPacket MultiRadio (FPMR) though a channel. The order from the Bosnian system integrator for third-generation, all-outdoor Harmony Enhanced packet microwave radios marks the beginning of a joint direct commercial relationship and a transition to DragonWave next generation technology.
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) caters to the Healthcare space. Its weekly performance is 5.32%. On the last day of trading company shares ended up at $5.54. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) distance from 50-day simple moving average (SMA50) is 7.89%.
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)‘s stock had its “buy” rating reissued by investment analysts at Needham & Company LLC in a research note issued to investors on Monday, MarketBeat Ratings reports.
Leave a Reply